Compare Ceigall India with Similar Stocks
Dashboard
High Management Efficiency with a high ROCE of 17.44%
With a growth in Net Profit of 78.24%, the company declared Very Positive results in Mar 26
With ROCE of 17.1, it has a Fair valuation with a 2.2 Enterprise value to Capital Employed
Increasing Participation by Institutional Investors
Market Beating Performance
Stock DNA
Construction
INR 5,791 Cr (Small Cap)
19.00
34
0.00%
0.44
14.59%
2.67
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Sep-23-2024
Risk Adjusted Returns v/s 
Returns Beta
News

Ceigall India Ltd Valuation Turns Attractive Amid Strong Market Performance
Ceigall India Ltd, a small-cap player in the construction sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change reflects improved price metrics relative to its historical averages and peer group, underpinned by solid operational performance and a robust return profile. Investors are now reassessing the stock’s price attractiveness amid a backdrop of strong fundamentals and a positive market outlook.
Read full news article
Ceigall India Ltd is Rated Buy
Ceigall India Ltd is rated Buy by MarketsMOJO, with this rating last updated on 07 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Ceigall India Ltd Valuation Turns Attractive Amid Strong Market Outperformance
Ceigall India Ltd, a small-cap player in the construction sector, has seen its valuation parameters shift favourably, moving from a fair to an attractive rating. This change comes amid robust stock performance that has outpaced the broader Sensex, signalling renewed investor interest and improved market sentiment towards the company.
Read full news article Announcements 
Corporate Actions 
No Upcoming Board Meetings
Ceigall India Ltd has declared 10% dividend, ex-date: 23 Sep 24
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 4 Schemes (1.58%)
Held by 26 FIIs (3.14%)
Ramneek Sehgal And Sons Huf . (37.28%)
Icici Prudential Life Insurance Company Limited (3.71%)
7.12%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 39.89% vs 22.88% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 70.84% vs 27.80% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 3.15% vs 14.64% in Sep 2024
Growth in half year ended Sep 2025 is -24.23% vs 24.33% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 8.69% vs 16.27% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -15.75% vs 11.53% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 17.04% vs 13.45% in Mar 2025
YoY Growth in year ended Mar 2026 is 6.08% vs -3.96% in Mar 2025






